| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.43 | 0.01 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.38 | 0.03 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.37 | 0.004 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.35 | 0.04 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.34 | 0.01 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.3 | 0.06 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.23 | 0.06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.19 | 0.0002 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.18 | 0.3 |